Methotrexate Clinical Trial
Official title:
Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis
Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA). Poor adherence
of this treatment decreases the control of the disease and the effectiveness of the
associated treatments.
The aim would be to study the observance of patients with RA and to be able to propose
adequate solutions favoring patient compliance and thus the stability of the pathology.
For this purpose, 3 methods of communication have been put in place to encourage adherence:
usual care by the rheumatologist, sms sending or pharmaceutical maintenance.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02897011 -
2-week dc of MTX and Influenza Vaccination in RA
|
N/A | |
| Not yet recruiting |
NCT04971239 -
Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis
|
Phase 4 | |
| Completed |
NCT00184886 -
The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans
|
N/A | |
| Recruiting |
NCT04299971 -
Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
|
Phase 4 | |
| Completed |
NCT03531593 -
Dose Effect Relationship of MTX and IBD
|
||
| Recruiting |
NCT05040464 -
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
|
Phase 3 |